Allianz Asset Management’s Core Laboratories CLB Stock Holding History

Allianz Asset Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-32,175	Closed	-$2.22M	–	2690
2019 Q1	$2.22M	Buy	+32,175	New	+$2.16M	﹤0.01%	1809
2018 Q4	–	Sell	-36,785	Closed	-$4.26M	–	2608
2018 Q3	$4.26M	Hold	36,785	–	–	﹤0.01%	1636
2018 Q2	$4.64M	Sell	36,785 -39,760	-52%	-$4.84M	﹤0.01%	1560
2018 Q1	$8.28M	Buy	76,545 +20,410	+36%	+$2.26M	0.01%	1334
2017 Q4	$6.15M	Buy	56,135 +50,935	+980%	+$5.08M	﹤0.01%	1534
2017 Q3	$513K	Hold	5,200	–	–	﹤0.01%	2410
2017 Q2	$519K	Buy	+5,200	New	+$561K	﹤0.01%	2402
2015 Q1	–	Sell	-876	Closed	-$105K	–	2247
2014 Q4	$105K	Sell	876 -93	-10%	-$12.2K	﹤0.01%	2265
2014 Q3	$142K	Sell	969 -2,314	-70%	-$357K	﹤0.01%	2205
2014 Q2	$548K	Sell	3,283 -5,844	-64%	-$1.04M	﹤0.01%	1557
2014 Q1	$1.81M	Sell	9,127 -27,760	-75%	-$5.24M	﹤0.01%	1241
2013 Q4	$7.04M	Sell	36,887 -2,337	-6%	-$435K	0.01%	849
2013 Q3	$6.64M	Sell	39,224 -445	-1%	-$69.1K	0.01%	828
2013 Q2	$6.02M	Buy	+39,669	New	+$5.62M	0.01%	824

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Allianz Asset Management's CLB Position: Q2 2019 in Review

Allianz Asset Management sold out of Core Laboratories (CLB) in Q2 2019, closing a stake of 32,175 shares — an estimated $2.22M sold.

Allianz Asset Management first reported a position in CLB in Q2 2013 and held it in 14 quarters. The position peaked at $8.28M in Q1 2018. 304 funds tracked by Wall St. Rank hold CLB as of Q2 2019.

Allianz Asset Management reported no remaining Core Laboratories position as of Q2 2019 after selling out during the quarter.
Allianz Asset Management sold 32,175 Core Laboratories shares in Q2 2019, an estimated $2.22M.
Allianz Asset Management first reported a position in Core Laboratories in Q2 2013 and held it in 14 quarters.
Allianz Asset Management's Core Laboratories position peaked at $8.28M in Q1 2018.
304 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2019.

Based on Allianz Asset Management's 13F filing for Q2 2019, filed 8 Aug 2019.